SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-122857
Filing Date
2021-04-20
Accepted
2021-04-20 16:23:00
Documents
15
Period of Report
2021-04-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d119708d8k.htm   iXBRL 8-K 37982
2 EX-3.2 d119708dex32.htm EX-3.2 34450
3 EX-3.4 d119708dex34.htm EX-3.4 181185
4 EX-99.1 d119708dex991.htm EX-99.1 3996
  Complete submission text file 0001193125-21-122857.txt   436177

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmea-20210420.xsd EX-101.SCH 3094
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20210420_lab.xml EX-101.LAB 18874
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20210420_pre.xml EX-101.PRE 11873
8 EXTRACTED XBRL INSTANCE DOCUMENT d119708d8k_htm.xml XML 3555
Mailing Address 726 MAIN STREET REDWOOD CITY CA 94063
Business Address 726 MAIN STREET REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 21838112
SIC: 2834 Pharmaceutical Preparations